- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 41/10 - Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
Patent holdings for IPC class A61K 41/10
Total number of patents in this class: 61
10-year publication summary
0
|
3
|
4
|
5
|
5
|
11
|
11
|
6
|
10
|
4
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Baxter International Inc. | 2425 |
3 |
Baxter Healthcare S.A. | 1810 |
3 |
Evelo Biosciences, Inc. | 135 |
3 |
Prolong Pharmaceuticals, LLC | 12 |
3 |
Sami Labs Limited | 114 |
2 |
Sun Pharmaceutical Industries Limited | 706 |
2 |
Terumo BCT Biotechnologies, LLC | 41 |
2 |
Ascendis Pharma A/S | 173 |
2 |
Anteris AUS Operations Pty Ltd | 10 |
2 |
Société des Produits Nestlé S.A. | 9672 |
1 |
The Regents of the University of California | 18943 |
1 |
Janssen Pharmaceutica N.V. | 3839 |
1 |
The Regents of the University of Michigan | 4409 |
1 |
Fraunhofer-Gesellschaft zur Foerderung der angewandten Forschung e.V. | 4569 |
1 |
Abbvie Inc. | 1808 |
1 |
Aarhus Universitet | 370 |
1 |
Advanced BioAdjuvants, LLC | 3 |
1 |
Amryt Research Limited | 20 |
1 |
Case Western Reserve University | 1727 |
1 |
Colorado State University Research Foundation | 675 |
1 |
Other owners | 28 |